Comments

Entero Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Entero Therapeutics (ENTO) operate in?

Entero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ENTONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.3782

-0.00280-0.73%

At close: -

$0.3620

-0.02-4.28%

After Hours: 6:13 PM EDT

Entero Therapeutics (ENTO) Forecast

News Earnings Entero Therapeutics (ENTO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Entero Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ENTO | Benzinga

Explore Entero Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ENTO.

Open	$0.39
Close	$0.38
Volume / Avg.	96.40K / 649.25K
Day Range	$0.36 - $0.39
52 Wk Range	0.19 - 3.16
Market Cap	$1.73M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	2.57%
Days to Cover	1.97

Recent News

Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.39
Close	$0.38
Volume / Avg.	96.40K / 649.25K
Day Range	$0.36 - $0.39
52 Wk Range	0.19 - 3.16
Market Cap	$1.73M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	2.57%
Days to Cover	1.97

About Entero Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the developmen...

Got Questions? Ask

Analyze ENTO's financials

Show ENTO's technical analysis

What are analysts' targets for ENTO?

What is ENTO's current price trend?

What is ENTO's current ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Entero Therapeutics (ENTO) stock?

You can purchase shares of Entero Therapeutics (NASDAQ:ENTO) through any online brokerage.

View our list of the best stock brokerages

Who are Entero Therapeutics (ENTO) competitors?

Other companies in Entero Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Tharimmune (NASDAQ:THAR), Genprex (NASDAQ:GNPX), AquaBounty Techs (NASDAQ:AQB) and TransCode Therapeutics (NASDAQ:RNAZ).

What is the forecast, or price target, for Entero Therapeutics (ENTO) stock?

There is no analysis for Entero Therapeutics to provide a consensus price target.

What is the current price for Entero Therapeutics (ENTO)?

The stock price for Entero Therapeutics (NASDAQ: ENTO) is $0.362 last updated April 17, 2025 at 6:13 PM EDT.

Does Entero Therapeutics (ENTO) pay a dividend?

There are no upcoming dividends for Entero Therapeutics.

When is Entero Therapeutics (NASDAQ:ENTO) reporting earnings?

Entero Therapeutics’s Q4 earnings are confirmed for Tuesday, May 20, 2025.

Is Entero Therapeutics (ENTO) going to split?

There is no upcoming split for Entero Therapeutics.

What sector and industry does Entero Therapeutics (ENTO) operate in?

Entero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.